Development of new generation non-live nanoparticle-based vaccines and novel delivery platforms is one of our main research interests. Specific expertise of the group include vaccine antigen design (enteric viruses, ETEC, influenza, tuberculosis), as well as state-of-the-art methods for assessment of immune responses to vaccinations and infections.
Contact persons
Vesna Blazevic, Ph.D.
Head of Laboratory, Group Leader
email. vesna.blazevic [at] tuni.fi
tel. +358 50 421 1054
Vaccine Development and Immunology Unit
Arvo Ylpön katu 34, 33520 Tampere, Finland